SISC Achieves and Maintains Reduced Average PMPM Over 10 Years with Navitus

Finding a PBM Partner with Aligned Goals

Self-Insured Schools of California (SISC), the largest health benefits pool of public schools in the United States, wanted what many other public schools want: to offer stable, affordable benefits to the school districts under their umbrella of service.

As with other similar coalitions, SISC was advised to maximize rebate income and switch members from retail to mail order. And like so many others given the same guidance, SISC saw limited returns for their efforts.

SISC recognized what they really needed was a Pharmacy Benefit Manager (PBM) that aligned with their goals of keeping the cost of benefits low and the quality of care high.

Collaboration to Deliver Savings Opportunities

SISC partnered with Navitus in 2014 and was able to lower costs—without sacrificing clinically-effective care by:

  • Implementing a custom, high-performance formulary to eliminate waste
  • Eliminating more than 600 unnecessary drugs
  • Implementing a comprehensive prior authorization (PA) process and a step therapy program to support lower-cost treatment options

And thanks to careful and collaborative implementation, members transitioned with minimal disruption.

Delivering Savings Beyond the First Year

SISC saw a 13.4% decrease in total new cost per member per month (PMPM) in their first year—despite the release of new, high-cost medications.

In the decade since, SISC has achieved $608 million in rebates and has had more than 26 million claims processed. More importantly, in an industry where costs continue to increase year over year, SISC has seen minimal increases to its pharmacy benefit costs, with an average total net cost PMPM of $80.15 over 10 years. This is less than their PMPM in 2013.

Ready to lower your pharmacy benefit costs?

Contact us at [email protected].

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Examining Trends that Drive Informed Decisions

Now Available: 8th Annual Drug Trend Report

See the latest results and access industry insights you need to navigate current trend drivers.

Related blogs

Navigating Healthcare and Improving Outcomes

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Authors: Justin Arzt, PharmD; Agata Siwak, PharmD, MSBA; Marnie Wickizer, PharmD, AE-C, CDCES; Ryan Schmidt, PharmD; Robert Topp, RN, PhD; Matt Hustad, PharmD All authors are employees of Navitus Health Solutions. Abstract Adalimumab biosimilar adoption…

PBM 101: Why the Model Matters

PBM 101: Why the Model Matters

In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are conduits of expertise, analytics and savings opportunities, poised to deliver exceptional health care while driving down costs. They coordinate between drug manufacturers,…

Associate Resource Group Spotlight: Green Team

Associate Resource Group Spotlight: Green Team

The Green Team believes that small changes lead to significant impact. Whether its reducing waste, conserving energy or implementing eco-friendly initiatives, they serve as an internal hub for expertise regarding environmental sustainability….

PBM 101: The Three PBM Business Models

PBM 101: The Three PBM Business Models

In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are regarded by the media as intermediaries between drug manufacturers, pharmacies, health plans and plan sponsors. But they’re so much more than that. PBMs act as conduits…

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

This study examines the impact of implementing an automated point-of-sale diagnosis verification system for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared to traditional utilization management approaches….

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

As the nation’s first 100% transparent, pass-through PBM, we continue to advance medication affordability by prioritizing upfront, real-time savings over rebated models….

Achieving Outstanding Results with Tailored Network Strategies

Achieving Outstanding Results with Tailored Network Strategies

A medium-sized city in Michigan with 1,350 members was seeking ways to lower its pharmacy benefit costs, which were growing under its existing traditional pharmacy benefit manager (PBM). With its member covered by a two-tier, open formulary including…

Breaking Through Barriers with Value-Based Plan Design

Breaking Through Barriers with Value-Based Plan Design

Facing increased pharmacy benefit expenses, Blain’s Farm and Fleet, a Midwestern employer group, desired to improve plan performance. Specifically it was interested in educating eligible members about the benefits available to them, promoting cost-effective…

Finding a Solution to Lower Prescription Drug Costs

Finding a Solution to Lower Prescription Drug Costs

The Rural Arizona Group Health Trust (RAGHT) wanted to gain better control of its escalating drug trend with its large, traditional pharmacy benefit manager (PBM). Having only worked with traditional PBMs in the past, RAGHT was interested in exploring…

previous arrow
next arrow